arrow
D

Daniela S. Krause

university medicine mainz
H指数:36
被引数:8,224

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Development of a Potent LIMK2 Isoform-Specific Degrader

LIMK2异构体特异性降解剂的发现与开发

2026-05-010
OA
DNA-protein cross-links promote cGAS-STING–driven premature aging and embryonic lethality

DNA-蛋白质交联促进cGAS-STING驱动的过早衰老和胚胎致死率

Science
IF45.8
2026-01-290
PRE
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective Inhibitor

共价靶向导致LIMK1亚型选择性抑制剂的研发

2025-07-020
OA
Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor
2025-04-010
OAAI
Engineering an inducible leukemia- associated fusion protein enables large- scale ex vivo production of functional human phagocytes
2024-06-100
OAAI
Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageing

亲环蛋白A支持内在无序蛋白质的翻译并影响造血干细胞的衰老

2024-03-294
OA
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia
LEUKEMIA
IF13.4
2023-11-073
OAAI
Distinct and targetable role of calcium-sensing receptor in leukaemia
2023-10-066
OAAI
Germline variants drive myelodysplastic syndrome in young adults

种系变异导致年轻人的骨髓增生异常综合征

LEUKEMIA
IF13.4
2021-01-2847
OA
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function

mRNA m6A reader YTHDF2抑制促炎途径并维持造血干细胞功能

2020-11-06106
OAAI
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia
LEUKEMIA
IF13.4
2020-05-2126
OAAI